Consolidative immunotherapy

DRUG3 trials

Sponsors

Sun Yat-sen University

Conditions

Concurrent ChemoradiotherapyImmunotherapyLocally Advanced Non-Small Cell Lung CancerNeoadjuvant TherapyNon-small Cell Lung Cancer

Phase 3

Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI

RecruitingNCT06545747

Sun Yat-sen UniversityNon-small Cell Lung Cancer

Start: 2024-08-01End: 2028-07-31Target: 490Updated: 2026-04-06

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

RecruitingNCT06734702

Sun Yat-sen UniversityConcurrent Chemoradiotherapy, Immunotherapy, Locally Advanced Non-Small Cell Lung Cancer +1

Start: 2024-11-30End: 2028-11-29Target: 497Updated: 2025-07-24

Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC

RecruitingNCT07052669

Sun Yat-sen UniversityLocally Advanced Non-Small Cell Lung Cancer

Start: 2025-07-01End: 2029-06-30Target: 311Updated: 2025-07-23